发明名称 |
SUSTAINED RELEASE DRUG FOR OPHTHALMOLOGY AND ITS PRODUCTION |
摘要 |
PROBLEM TO BE SOLVED: To provide a sustained release drug for ophthalmology excellent in biodegradability and safety in the eye by using hyaluronic acid or a crosslinking product or its salt as a base and a method for producing it. SOLUTION: This sustained release drug for ophthalmology is obtained by mixing a prescribed drug for ophthalmology with hyaluronic acid having (40-180)×104 weight-average molecular weight or its salt and an epoxy compound expressed by following structural formula (n) is 0 or 1} and crosslinking the hyaluronic acid or its salt with an epoxy compound by heating, and carrying the drug for ophthalmology to the resultant crosslinked product.
|
申请公布号 |
JP2000119196(A) |
申请公布日期 |
2000.04.25 |
申请号 |
JP19980284894 |
申请日期 |
1998.10.07 |
申请人 |
MENICON CO LTD |
发明人 |
NAKADA KAZUHIKO;KONDO NAOKI |
分类号 |
A61K45/00;A61F2/16;A61K31/00;A61K47/30;A61P27/00;A61P27/02;(IPC1-7):A61K47/30 |
主分类号 |
A61K45/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|